Cabrera-Zavala A, Soria-Céspedes D, Arce-Alcázar A

Language: Spanish
References: 11
Page: 1-7
PDF size: 227.90 Kb.

ABSTRACT

Clinical case description: A 63-year-old man with gastrointestinal symptoms without history of kidney disease. Through an abdominal computed axial tomography study, two lesions were detected in the right kidney that were resected. By morphology both lesions showed papillary pattern with clear cell features, low grade and fibromuscular stroma. By immunohistochemistry cytokeratin 7, cytokeratin 34βE12, carbonic anhydrase IX, PAX8, parafibromin and vimentin were positive, while CD10, AMARC, RCC, TFE3 were negative.
Clinical implications: Clear cell papillary renal cell tumor (CCPRCT) is a recognized entity that has a unique morphologic and immunohistochemical features with an indolent clinical behavior with no recurrences, metastases or lymph node involvement. It was initially described in conjunction with end-stage renal disease; however, sporadic cases have been described in patients without kidney disease. It is important to correctly differentiate from other subtypes with worse prognosis.
Relevance: CCPRCT previously called carcinoma has changed its name in the latest WHO publication (2022) due to the absence of cases with metastasis or recurrence, it is an indolent neoplasm that must be differentiated from other more aggressive tumors.
Conclusions: CCPRCT can occur in patients without history of renal disease, it has an excellent prognosis, partial or total nephrectomy is the treatment of choice. The pathologist must differentiate it from other renal cell tumors with more aggressive behavior.

REFERENCES

1. Moch H, Amin MB, Berney DM, Compérat EM,Gill AJ, Hartmann A, et al. The 2022 WorldHealth Organization Classification of Tumoursof the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours.European Urology. 2022;82(5): 458–468.https://doi.org/10.1016/j.eururo.2022.06.016.

2. Gobbo S, Eble JN, Grignon DJ, MartignoniG, MacLennan GT, Shah RB, et al. Clear cellpapillary renal cell carcinoma: a distincthistopathologic and molecular genetic entity.The American Journal of Surgical Pathology.2008;32(8): 1239–1245. https://doi.org/10.1097/pas.0b013e318164bcbb.

3. Zhou H, Zheng S, Truong LD, Ro JY, Ayala AG,Shen SS. Clear cell papillary renal cell carcinomais the fourth most common histologic typeof renal cell carcinoma in 290 consecutivenephrectomies for renal cell carcinoma. HumanPathology. 2014;45(1): 59–64. https://doi.org/10.1016/j.humpath.2013.08.004.

4. Zhao J, Eyzaguirre E. Clear Cell PapillaryRenal Cell Carcinoma. Archives of Pathology &Laboratory Medicine. 2019;143(9): 1154–1158.https://doi.org/10.5858/arpa.2018-0121-rs.

5. Aron M, Chang E, Herrera L, Hes O, HirschMS, Comperat E, et al. Clear cell-papillary renalcell carcinoma of the kidney not associatedwith end-stage renal disease: clinicopathologiccorrelation with expanded immunophenotypicand molecular characterization of a largecohort with emphasis on relationship withrenal angiomyoadenomatous tumor. TheAmerican Journal of Surgical Pathology.2015;39(7): 873–888. https://doi.org/10.1097/pas.0000000000000446.

6. Shao T, Yousef P, Shipilova I, Saleeb R, LeeJY, Krizova A. Clear cell papillary renal cellcarcinoma as part of histologically discordantmultifocal renal cell carcinoma: A case reportand review of literature. Pathology, Researchand Practice. 2016;212(3): 229–233. https://doi.org/10.1016/j.prp.2015.12.007.

7. Anderson DA, Tretiakova MS. Primary RenalCarcinoid with Bilateral Multiple ClearCell Papillary Renal Cell Carcinomas. CaseReports in Pathology. 2017;2017. https://doi.org/10.1155%2F2017%2F9672368.

8. Shi SS, Shen Q, Xia QY, Tu P, Shi QL, Zhou XJ,et al. Clear cell papillary renal cell carcinoma:a clinicopathological study emphasizingultrastructural features and cytogeneticheterogeneity. International Journal of Clinicaland Experimental Pathology. 2013;6(12): 2936–2942.

9. Alexiev BA, Drachenberg CB. Clear cell papillaryrenal cell carcinoma: Incidence, morphologicalfeatures, immunohistochemical profile, andbiologic behavior: A single institution study.Pathology, Research and Practice. 2014;210(4):234–241. https://doi.org/10.1016/j.prp.2013.12.009.

10. Morlote DM, Harada S, Batista D, GordetskyJ, Rais-Bahrami S. Clear cell papillaryrenal cell carcinoma: molecular profileand virtual karyotype. Human Pathology.2019;91: 52–60. https://doi.org/10.1016/j.humpath.2019.05.011.

11. Cui C, Ziober A, Bing Z. Expression of parafibrominin clear cell papillary renal cell carcinoma.Applied immunohistochemistry & molecularmorphology: AIMM. 2013;21(4): 322–325.https://doi.org/10.1097/pai.0b013e31827362c9.